SHIELDS MATTHEW (EVP, Global Operations) sold 38.3% of their position (6.21K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $105.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/5/2025ACC: 0000950170-25-082498
Officer· EVP, Global Operations
Since Mar 2026
-6.21K
Net shares
Net seller
$105.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.20K acquired · 22.40K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+16.20K
Price / share
—
Trade value
—
% of position
New position
6/3/2025
0.00→16.20K
Ordinary Shares
Direct
Shares
−6.21K
Price / share
$17.02
Trade value
$105.63K
% of position
38.3%
6/3/2025
16.20K→9.99K
Total
Net shares
+9.99K
Net value
-$105.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/3/2025 | M · Option Exercise | +16.20K | — | — | New position | 0.00 | 16.20K |
| Ordinary Shares Direct | 6/3/2025 | S · Sale | −6.21K | $17.02 | $105.63K | 38.3% | 16.20K | 9.99K |
| Total | +9.99K | -$105.63K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
16.20K shares
Shares
−16.20K
Strike price
Held after
48.59K
Exercisable
—
6/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares16.20K shares | 6/3/2025 | M · Option Exercise | −16.20K | — | 48.59K |